Investigational New Drugs
| Investigational New Drugs
|
|
|---|---|
| description | Peer-reviewed journal |
| Area of Expertise | Medicine and pharmacology |
| language | English |
| publishing company | Springer ( United States of America ) |
| First edition | 1983 |
| Frequency of publication | 6 issues per year |
| Web link | Website of the journal |
| ISSN (print) | 0167-6997 |
Investigational New Drugs , or Invest for short . New Drugs , is a scientific journal published by Springer-Verlag. The magazine is currently published six times a year. Works are published that deal with new drugs for oncological therapy.
The impact factor in 2015 was 3.281. According to the statistics of the ISI Web of Knowledge , the journal with this impact factor ranks 84th out of 213 journals in the oncology category and 89th out of 254 journals in the pharmacology and pharmacy category.
Individual evidence
- ^ Website of the journal ; accessed on December 31, 2013.
- ↑ 2015 Journal Citation Reports, Science Edition (Thomson Reuters, 2016).